Home

Susan Mahony

CIK 1463321 · SVP & Pres., Lilly Oncology · last filed 2026-06-10

Susan Mahony is a SVP & Pres., Lilly Oncology who has filed 64 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for AXSM, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $66.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$66.05M

Companies

5

Total Filings

64

Lifetime Open-Market Net

-$13.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXSM Director 829 $212.74 $176.4K -$145.0K 7 2026-06-10
ASMB Director — $26.68 — $0 10 2026-06-05
ZYME Director — $23.54 — $0 6 2026-01-12
Horizon Therapeutics Public Ltd Co (HZNP) Delisted Director 0 $116.30 $0 $0 7 2023-10-06
LLY SVP & Pres., Lilly Oncology 55,559 $1185.71 $65.88M -$13.25M 32 2019-02-01

Recent Filings

64 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 AXSM Notice (144) −300 -$73.9K EDGAR
2026-06-10 AXSM Mixed +829 -$145.0K EDGAR
2026-06-09 AXSM Notice (144) −300 -$71.2K EDGAR
2026-06-09 AXSM Grant (A) — $0 EDGAR
2026-06-05 ASMB Grant (A) — $0 EDGAR
2026-01-12 ZYME Grant (A) — $0 EDGAR
2025-06-10 AXSM Grant (A) — $0 EDGAR
2025-06-09 ASMB Grant (A) — $0 EDGAR
2025-02-25 AXSM Grant (A) — $0 EDGAR
2024-12-12 ZYME Grant (A) — $0 EDGAR
Showing 1–10 of 64
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.